Dermal peptides
The dermal category covers peptides studied in skin-biology, cosmetic-formulation, and melanocortin-receptor research. The flagship is the copper tripeptide GHK-Cu — biologically active as the 1:1 Cu²⁺ complex, supplied as a deep-blue lyophilised cake (the colour is the unmistakable signature of intact copper coordination).
Adjacent SKUs include Melanotan I (the linear α-MSH analogue afamelanotide, approved as Scenesse® for EPP) and Melanotan II (the cyclic non-selective melanocortin agonist), the FDA-approved bremelanotide (PT-141, Vyleesi®) supplied as research-grade peptide, the SNAP-25 octapeptide Snap-8, and the proprietary multi-peptide Glow blend (vial + pen formats).
- SKUs in class
- 8
- Median purity
- ≥ 99%
- Verified by
- Janoshik · SVK
GHK-Cu 100 mg
Copper-bound tripeptide Gly-His-Lys.
- Form
- Lyophilised kit
- Dose
- 100 mg / vial
- Purity
- ≥ 99.6%
GHK-Cu 150 mg pen
Pre-filled copper-tripeptide pen — high-dose presentation.
- Form
- Pre-filled pen
- Dose
- 150 mg / pen
- Purity
- ≥ 99.6%
Glow Blend 70 mg
Multi-peptide dermal blend — GHK-Cu + supporting peptides.
- Form
- Lyophilised kit
- Dose
- 70 mg / vial
- Purity
- ≥ 99.0% (component-level)
Glow Blend 140 mg pen
Pre-filled dermal-blend pen — 140 mg presentation.
- Form
- Pre-filled pen
- Dose
- 140 mg / pen
- Purity
- ≥ 99.0% (component-level)
Melanotan II 10 mg
Melanocortin-receptor agonist — cyclic heptapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Melanotan I 10 mg
Linear α-MSH analogue — MC1R-selective melanocortin agonist.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
PT-141 10 mg
Approved MC3R/MC4R agonist — cyclic heptapeptide.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%
Snap-8 10 mg
Cosmetic octapeptide — argireline extension analogue.
- Form
- Lyophilised kit
- Dose
- 10 mg / vial
- Purity
- ≥ 99.0%